FDA to convene expert panel on wider peptide access
The item appears in a Medical Economics daily roundup alongside unrelated care-model and Medicare fraud news.
DO
By Daniel Okafor · Regulatory Correspondent
Sep 13 02:15 ETSource: Medical Economics
The wire
- 01Medical Economics reports in its September 13 morning update that the FDA plans to convene an expert panel on broader access to peptides.
- 02Any FDA panel on peptide access bears directly on compounders, telehealth prescribers and clinicians working with peptides currently off the approved-drug list.
- 03The roundup gives no panel date, membership or scope; readers should wait for an FDA notice before drawing conclusions about which peptides are in play.
From the source
Read at medicaleconomics.comTeam-based care model cuts blood pressure in high-risk populations; FDA to convene expert panel on wider access to peptides; Florida nursing assistant sentenced in $11.4M Medicare brace fraud scheme – Morning Medical Update